Literature DB >> 1651323

Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation. Characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase.

E Alvarez1, I C Northwood, F A Gonzalez, D A Latour, A Seth, C Abate, T Curran, R J Davis.   

Abstract

A growth factor-stimulated (MAP2-related) protein kinase, ERT, that phosphorylates the epidermal growth factor receptor at Thr669 has been purified from KB human tumor cells by Northwood and co-workers (Northwood, I. C., Gonzalez, F. A., Wartmann, M., Raden, D. L., and Davis, R. J. (1991) J. Biol. Chem. 266, 15266-15276). The ERT protein kinase has a restricted substrate specificity, and the structural determinants employed for substrate recognition by this enzyme have not been defined. As an approach toward understanding the specificity of substrate phosphorylation, we have used an in vitro assay to identify additional substrates for the ERT protein kinase. In this report we describe two novel substrates: (a) the human c-myc protein at Ser62 and (b) the rat c-jun protein at Ser246. Alignment of the primary sequences surrounding the phosphorylation sites located within the epidermal growth factor receptor (Thr669), Myc (Ser62), and Jun (Ser246) demonstrated a marked similarity. The observed consensus sequence was Pro-Leu-Ser/Thr-Pro. We propose that this sequence forms part of a substrate structure that is recognized by the ERT protein kinase.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1651323

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  140 in total

1.  Activation of cJUN N-terminal kinase by herpes simplex virus type 1 enhances viral replication.

Authors:  T I McLean; S L Bachenheimer
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals.

Authors:  D W Chang; G F Claassen; S R Hann; M D Cole
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

3.  Cytokine-responsive induction of SAF-1 activity is mediated by a mitogen-activated protein kinase signaling pathway.

Authors:  Alpana Ray; Guang-Yao Yu; Bimal K Ray
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

4.  ets-2 is a target for an akt (Protein kinase B)/jun N-terminal kinase signaling pathway in macrophages of motheaten-viable mutant mice.

Authors:  J L Smith; A E Schaffner; J K Hofmeister; M Hartman; G Wei; D Forsthoefel; D A Hume; M C Ostrowski
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

5.  Stress-stimulated mitogen-activated protein kinases control the stability and activity of the Cdt1 DNA replication licensing factor.

Authors:  Srikripa Chandrasekaran; Ting Xu Tan; Jonathan R Hall; Jeanette Gowen Cook
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

Review 6.  Cell cycle and apoptosis.

Authors:  Katrien Vermeulen; Zwi N Berneman; Dirk R Van Bockstaele
Journal:  Cell Prolif       Date:  2003-06       Impact factor: 6.831

7.  Selective activation of p42 mitogen-activated protein (MAP) kinase in murine B lymphoma cell lines by membrane immunoglobulin cross-linking. Evidence for protein kinase C-independent and -dependent mechanisms of activation.

Authors:  M R Gold; J S Sanghera; J Stewart; S L Pelech
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

8.  Inhibition of c-Jun DNA binding by mitogen-activated protein kinase.

Authors:  S Y Chou; V Baichwal; J E Ferrell
Journal:  Mol Biol Cell       Date:  1992-10       Impact factor: 4.138

Review 9.  Nuclear protein phosphorylation and growth control.

Authors:  D W Meek; A J Street
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

10.  Cell membrane stretch activates intermediate-conductance Ca2+-activated K+ channels in arterial smooth muscle cells.

Authors:  Yasunobu Hayabuchi; Yutaka Nakaya; Kazuaki Mawatari; Miki Inoue; Miho Sakata; Shoji Kagami
Journal:  Heart Vessels       Date:  2010-11-10       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.